In a report released today, Michael Ryskin from Bank of America Securities maintained a Hold rating on 10x Genomics (TXG – Research Report).

CEO Serge Saxonov, PhD, says provider of single cell, spatial, and in situ instruments expects to see benefits from sales ...

10X Genomics, Inc. is a life science technology company, which engages in building products to interrogate, understand and master biology. Its integrated solutions include single cell ...

The Saint Louis University Genomics Core Facility offers primarily single cell genomics and bioinformatics services to both internal and external users. The goal of the Core is to make genomics-based ...

10x Genomics excels in single-cell and spatial technologies but faces significant challenges. Despite an EPS beat, revenue fell 1% due to sales disruption and competitive pricing. The company's ...

For instance, Visium from 10x Genomics captures information about the expression of all genes in a tissue, but does not provide single-cell resolution. In contrast, the 10x Genomics Xenium assay ...

This repository provides a comprehensive analysis pipeline designed for the processing and visualization of single ... by 10X Genomics. This dataset contains transcriptomic information derived from ...

Methods Single-cell RNA sequencing was performed by droplet-based sequencing (10x Genomics), focusing on 3729 CD3 + lymphocytes ... signature and that appears to be poised to promote B-cell responses ...